Skip to content

Insider · CIK 0001250893

Gayle A Crowell

director

Files at HTGC (Hercules Capital, Inc.), ENV (ENVESTNET, INC.), PLRX (PLIANT THERAPEUTICS, INC.). First filing May 9, 2025, latest May 9, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$105k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

HTGC: Hercules Capital, Inc.

HTGCOct 9, 2026 · close 16.51

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
57Moderate
HTGCbuy 6
Hercules Capital, Inc.
$105k
5,999 shares
+9%+8% from low-18% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 5, 2025PLRX
PLIANT THERAPEUTICS, INC.
AGrant or award
Common Stock (Right to Buy)derivative
+30,000$0.00$030,000Jun 9, 2025
May 8, 2025HTGC
Hercules Capital, Inc.
POpen-market purchase
Common Stock
+5,999$17.49$105k69,344May 9, 2025
Nov 25, 2024ENV
ENVESTNET, INC.
DDisposition to issuer
Common Stock
-17,075$63.15$1.1M0Nov 25, 2024
Nov 25, 2024ENV
ENVESTNET, INC.
DDisposition to issuer
Common Stockindirect: By trust
-3,852$63.15$243k0Nov 25, 2024
Nov 25, 2024ENV
ENVESTNET, INC.
DDisposition to issuer
Stock Option (right to buy)derivative
-1,745--0Nov 25, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Gayle A Crowell: insider trades and track record | InsiderTell